Clovis Oncology and Avila Therapeutics to Collaborate on Novel Lung Cancer Drug
By Debbie Tranter
Pharma Deals Review: Vol 2010 Issue 5 (Table of Contents)
Published: 3 Jun-2010
DOI: 10.3833/pdr.v2010.i5.1347 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Clovis Oncology Inc will pay up to USD 209 M for joint development of Avila Therapeutics’ innovative treatment for non-small cell lung cancer (NSC
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS